Conservative Site-specific Recombination and Phase Variation
CRISPR
CRISPR/Cas9 Genome Editing
Epigenetic Regulation
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Oct 13, 2025

A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis
Published on: March 8, 2022
Jim Smith1, Rakesh Banerjee1, Reema Waly1
1Department of Pathology, Otago Medical School, University of Otago, Dunedin 9054, New Zealand.
This study introduces a CRISPR-based tool for precise DNA methylation editing in melanoma cells. The technology effectively modifies the EBF3 promoter, offering new avenues for cancer research and therapeutic development.
07:23Dual CRISPR-Interference Strategy for Targeting Synthetic Lethal Interactions Between Non-Coding RNAs in Cancer Cells
Published on: May 30, 2025
13:47Lentiviral Vector Platform for the Efficient Delivery of Epigenome-editing Tools into Human Induced Pluripotent Stem Cell-derived Disease Models
Published on: March 29, 2019
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: